A 62-year-old with chest pain and prior CABG is low risk after evaluation. Which biomarker strategy is endorsed by the chest pain guideline for early ...

Question

A 62-year-old with chest pain and prior CABG is low risk after evaluation. Which biomarker strategy is endorsed by the chest pain guideline for early rule-out?

Accepted Answer

High-sensitivity troponin measured serially with validated algorithms

Answer

Single conventional troponin at 0 hour

Answer

Creatine kinase MB only

Answer

Myoglobin levels

Answer

D-dimer testing

us-abem MCQ (SBA): ACS Evaluation

A 62-year-old with chest pain and prior CABG is low risk after evaluation. Which biomarker strategy is endorsed by the chest pain guideline for early rule-out?